Roche announced today it has acquired Boston-based Constitution Medical Investors Inc. in a deal worth at least $220 million.
Roche, of Nutley, will pay shareholders of CMI, a hematology testing firm, $220 million, with additional payments subject to various milestones.
According to the announcement, the technology Roche acquires in this deal is called "The Bloodhound" and provides faster and more accurate diagnosis of blood-related diseases. The technology replaces several pieces of traditional laboratory equipment with a single, smaller unit.
Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.View Comment Policy